OligoConnect: Linking Science, Innovation, and Therapeutics (Day 2)
Agilent: OligoConnect: Linking Science, Innovation, and Therapeutics
Join Us For This Innovative Oligo Virtual Event
Join some or all of the sessions over 13 & 14 March.
In recent years a renewed interest in synthetic oligonucleotides has been piqued due to their potential in biochemical research and for therapeutic applications. This popularity has meant a growing need to develop robust approaches for analysis and purification of oligos, alongside an increased understanding of this class of compounds.
Across 2 days this educational virtual event will share key learnings around the analysis of synthetic oligonucleotides, providing expert insights from research discovery to production QA/QC. We invite you to join along with other scientists in this important field to revisit oligo fundamentals, discover tips and tricks, ask questions to experts, and discuss recent innovations in this fast-moving environment.
Agenda:
Day 2
10:00 - More details to follow
10:45 - Oligonucleotide and Biopharmaceuticals Raw Materials Identification by Raman SORS and UV-VIS Thermal Melt Identification
- Paolo Scardina, Spectroscopy Product Specialist, Agilent Technologies
11:30 - Analysis of Elemental Impurities in Synthetic Oligonucleotides by ICP-MS
- Sebastien Sannac, Atomic Spectroscopy Product Specialist, Agilent Technologies
11:55 - Exploring the Applications and Innovations of Gas Chromatography-Mass Spectrometry (GC-MS) in Biopharmaceuticals
- Soma Dasgupta, Applications Engineer, Agilent
12:20 - Oligonucleotide Purity Analysis - Oligo Pro II
- Leslie Friedmann, Product Manager, Agilent Technologies